187 related articles for article (PubMed ID: 20880398)
1. The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.
Frølund S; Holm R; Brodin B; Nielsen CU
Br J Pharmacol; 2010 Oct; 161(3):589-600. PubMed ID: 20880398
[TBL] [Abstract][Full Text] [Related]
2. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
[TBL] [Abstract][Full Text] [Related]
3. Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1).
Frølund S; Marquez OC; Larsen M; Brodin B; Nielsen CU
Br J Pharmacol; 2010 Mar; 159(6):1339-53. PubMed ID: 20128809
[TBL] [Abstract][Full Text] [Related]
4. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxy-L-tryptophan alters gaboxadol pharmacokinetics in rats: involvement of PAT1 and rOat1 in gaboxadol absorption and elimination.
Larsen M; Holm R; Jensen KG; Sveigaard C; Brodin B; Nielsen CU
Eur J Pharm Sci; 2010 Jan; 39(1-3):68-75. PubMed ID: 19900542
[TBL] [Abstract][Full Text] [Related]
6. Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.
Nielsen CU; Frølund S; Abdulhadi S; Sari H; Langthaler L; Nøhr MK; Kall MA; Brodin B; Holm R
Br J Pharmacol; 2013 Nov; 170(5):1041-52. PubMed ID: 23962042
[TBL] [Abstract][Full Text] [Related]
7. Rectal absorption of vigabatrin, a substrate of the proton coupled amino acid transporter (PAT1, Slc36a1), in rats.
Holm R; Kall MA; Frølund S; Nielsen AL; Jensen A; Broberg ML; Nielsen CU
Pharm Res; 2012 Apr; 29(4):1134-42. PubMed ID: 22234618
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1.
Abbot EL; Grenade DS; Kennedy DJ; Gatfield KM; Thwaites DT
Br J Pharmacol; 2006 Feb; 147(3):298-306. PubMed ID: 16331283
[TBL] [Abstract][Full Text] [Related]
9. Transport of the areca nut alkaloid arecaidine by the human proton-coupled amino acid transporter 1 (hPAT1).
Voigt V; Laug L; Zebisch K; Thondorf I; Markwardt F; Brandsch M
J Pharm Pharmacol; 2013 Apr; 65(4):582-90. PubMed ID: 23488788
[TBL] [Abstract][Full Text] [Related]
10. Intestinal gaboxadol absorption via PAT1 (SLC36A1): modified absorption in vivo following co-administration of L-tryptophan.
Larsen M; Holm R; Jensen KG; Brodin B; Nielsen CU
Br J Pharmacol; 2009 Aug; 157(8):1380-9. PubMed ID: 19594759
[TBL] [Abstract][Full Text] [Related]
11. Indirect regulation of the intestinal H+-coupled amino acid transporter hPAT1 (SLC36A1).
Anderson CM; Thwaites DT
J Cell Physiol; 2005 Aug; 204(2):604-13. PubMed ID: 15754324
[TBL] [Abstract][Full Text] [Related]
12. Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells.
Larsen M; Larsen BB; Frølund B; Nielsen CU
Eur J Pharm Sci; 2008 Sep; 35(1-2):86-95. PubMed ID: 18621125
[TBL] [Abstract][Full Text] [Related]
13. Function and expression of the proton-coupled amino acid transporter PAT1 along the rat gastrointestinal tract: implications for intestinal absorption of gaboxadol.
Broberg Ml; Holm R; Tønsberg H; Frølund S; Ewon KB; Nielsen Al; Brodin B; Jensen A; Kall MA; Christensen KV; Nielsen CU
Br J Pharmacol; 2012 Oct; 167(3):654-65. PubMed ID: 22577815
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.
Sala-Rabanal M; Loo DD; Hirayama BA; Turk E; Wright EM
J Physiol; 2006 Jul; 574(Pt 1):149-66. PubMed ID: 16627568
[TBL] [Abstract][Full Text] [Related]
15. Gaboxadol has affinity for the proton-coupled amino acid transporter 1, SLC36A1 (hPAT1)--A modelling approach to determine IC(50) values of the three ionic species of gaboxadol.
Frølund S; Rapin N; Nielsen CU
Eur J Pharm Sci; 2011 Feb; 42(3):192-8. PubMed ID: 21112392
[TBL] [Abstract][Full Text] [Related]
16. Carrier-mediated γ-aminobutyric acid transport across the basolateral membrane of human intestinal Caco-2 cell monolayers.
Nielsen CU; Carstensen M; Brodin B
Eur J Pharm Biopharm; 2012 Jun; 81(2):458-62. PubMed ID: 22452873
[TBL] [Abstract][Full Text] [Related]
17. Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).
Anderson CM; Thwaites DT
Biochim Biophys Acta; 2007 Jul; 1768(7):1822-9. PubMed ID: 17498647
[TBL] [Abstract][Full Text] [Related]
18. Transport of the photodynamic therapy agent 5-aminolevulinic acid by distinct H+-coupled nutrient carriers coexpressed in the small intestine.
Anderson CM; Jevons M; Thangaraju M; Edwards N; Conlon NJ; Woods S; Ganapathy V; Thwaites DT
J Pharmacol Exp Ther; 2010 Jan; 332(1):220-8. PubMed ID: 19789362
[TBL] [Abstract][Full Text] [Related]
19. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
Omkvist DH; Brodin B; Nielsen CU
Br J Pharmacol; 2010 Dec; 161(8):1793-805. PubMed ID: 20726987
[TBL] [Abstract][Full Text] [Related]
20. The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters.
Geissler S; Zwarg M; Knütter I; Markwardt F; Brandsch M
FEBS J; 2010 Feb; 277(3):790-5. PubMed ID: 20067523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
